Alumis Inc. ALMS · SEC Filings

237

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercializ...

Price6.55

Market Cap847.8 M

Float91.35 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 13, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 19, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 13, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 13, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)

Sep 1, 2026

8-K

Alumis Reports Q2 2026 Financial Results and Provides Pipeline Updates

Aug 13, 2026

8-K

Alumis Announces Positive Long-Term Data for Envudeucitinib in Plaque Psoriasis

Aug 10, 2026

8-K

Alumis Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jul 2, 2026

8-K

Alumis Inc. Corporate Update on TYK2 Inhibitor Pipeline and Clinical Milestones

Jun 29, 2026

8-K

Alumis Reports Q1 2026 Financial Results and Provides Clinical Pipeline Updates

May 14, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Jan 8, 2026

424B5

PENDING FIXED PRICE OFFERING | Offering amount: $175,000,000 | Bank: Morgan Stanley, Leerink Partners, Cantor, Wells Fargo Securities

Jan 6, 2026

425

Form 425 - Prospectuses and communications, business combinations

Apr 29, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION

Apr 23, 2025

425

Form 425 - Prospectuses and communications, business combinations

Apr 21, 2025

425

Form 425 - Prospectuses and communications, business combinations

Apr 21, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-3ASR

March 2026 SHELF + ATM

Mar 19, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jan 30, 2026

S-3

July 2025 SHELF EFFECTIVE, DATED 2025-08-19

Jul 3, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 10, 2025

S-4

Form S-4 - Registration of securities, business combinations

Apr 21, 2025

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Apr 2, 2025

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT